ArticleLiver cancer2025

Tumor Mutational Burden as a Prognostic Biomarker for Relapse-Free Survival in Hepatocellular Carcinoma: Insights from Long-Term Follow-Up.

Yuya Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.